Sigyn Therapeutics, Inc.
SIGY
$2.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 51.67% | -68.27% | 11.81% | 55.55% | -32.15% |
| Total Depreciation and Amortization | -100.00% | -100.00% | -6.67% | -62.16% | 1,500.00% |
| Total Amortization of Deferred Charges | -47.63% | -52.43% | -3.55% | -81.45% | 35.93% |
| Total Other Non-Cash Items | -82.91% | 2,320.27% | 33.33% | -13.91% | 738.11% |
| Change in Net Operating Assets | -63.02% | -29.79% | -43.75% | -69.18% | 56.90% |
| Cash from Operations | -21.67% | 16.63% | -24.96% | -126.90% | 55.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -5.67% | -38.76% | 6.65% | 141.33% | -25.56% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.42% | -31.24% | 14.95% | 83.47% | -32.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.40% | -159.62% | -96.21% | -188.47% | 170.98% |